ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +4.4% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +8 | 116.88M | $20.55B | +11 | −4 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | n/a | 22.19M | $2.32B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 18.90M | +4.8% | $1.50B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 5.85M | +1.0% | $464.29M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.01M | -0.2% | $238.88M | 0.2% | ▼ Trim | 4 | SEC ↗ ×4 |
| 4 | Geode Capital Management ✦ (pasivo) | 2.85M | +4.2% | $225.46M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | PRIMECAP Management ✦ | 2.37M | -3.5% | $188.11M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 2.12M | +361.7% | $165.48M | 0.2% | ▲ Add | 4 | SEC ↗ ×7 |
| 7 | Renaissance Technologies ✦ | 1.09M | +20.4% | $86.45M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | ARK Investment Management ✦ | 895.32K | +30.4% | $71.03M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 459.54K | -37.4% | $36.46M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 332.31K | -37.5% | $26.37M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 306.55K | +3530.4% | $24.32M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Icahn Capital ✦ | 220.00K | +450.0% | $17.45M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 184.99K | +174.0% | $14.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 116.38K | +7.4% | $9.23M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 15 | D. E. Shaw & Co. ✦ | 75.16K | +115.1% | $5.96M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 16 | Norges Bank ✦ (pasivo) | 75.16K | -95.6% | $5.96M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 63.46K | +135.7% | $5.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Marshall Wace ✦ | 40.03K | Nuevo | $3.18M | 0.0% | New | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 37.21K | +47.1% | $2.95M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $3.18M | 0.0% |
Posición cerrada
| GAMCO Investors | $211,804 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 837 tenedores, 154.80M acciones, $18.58B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 7.50K acc. · $1.63M
Director · 11.35K acc. · $2.49M
Director · 100.65K acc. · $21.98M
Director · 13.26K acc. · $2.87M
Director · 9.96K acc. · $2.21M
Director · 6.66K acc. · $1.47M
Director · 13.72K acc. · $3.01M
Director · 9.72K acc. · $2.12M
Director · 14.20K acc. · $3.08M
Director · 8.44K acc. · $1.82M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología